Literature DB >> 29410051

Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications.

Srikar Mapakshi1, Jennifer R Kramer2, Peter Richardson2, Hashem B El-Serag2, Fasiha Kanwal2.   

Abstract

Large administrative databases using International Classification of Diseases (ICD) codes are useful for epidemiologic, health services, and outcomes research.1,2 However, coding accuracy of disease conditions could be a limiting factor. Cirrhosis prevalence is increasing because of an aging hepatitis C cohort and an increase in nonalcoholic steatohepatitis.3 We previously examined the validity of ICD, 9th revision (ICD-9), codes for cirrhosis in US Department of Veterans Affairs (VA) administrative databases.4,5 This work has formed the basis for many clinical, epidemiologic, and health services research studies. However, with transition from the ICD-9 to ICD, 10th revision (ICD-10), coding system, it is important to determine the validity of these new cirrhosis codes in administrative databases. Although the greater number of codes in the ICD-10 system may be associated with greater specificity and coding accuracy than with the ICD-9 system, this hypothesis remains untested.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29410051     DOI: 10.1016/j.cgh.2018.01.042

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  22 in total

1.  Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding.

Authors:  Andrew M Moon; Pamela K Green; Don C Rockey; Kristin Berry; George N Ioannou
Journal:  Aliment Pharmacol Ther       Date:  2019-11-27       Impact factor: 8.171

2.  Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.

Authors:  Amoah Yeboah-Korang; Jeremy Louissaint; Irene Tsung; Sharmila Prabhu; Robert J Fontana
Journal:  Drug Saf       Date:  2020-04       Impact factor: 5.606

3.  Cirrhosis Inpatients Receive More Opioids and Fewer Nonopioid Analgesics Than Patients Without Cirrhosis.

Authors:  Jessica B Rubin; Jennifer C Lai; Amy M Shui; Samuel F Hohmann; Andrew Auerbach
Journal:  J Clin Gastroenterol       Date:  2021-10-14       Impact factor: 3.062

4.  Validity of International Classification of Diseases, Tenth Revision, Codes for Cirrhosis.

Authors:  Nathan S Ramrakhiani; Michael H Le; Yee Hui Yeo; An K Le; Mayumi Maeda; Mindie H Nguyen
Journal:  Dig Dis       Date:  2020-08-19       Impact factor: 2.404

5.  Identifying Patients With Hepatic Encephalopathy Using Administrative Data in the ICD-10 Era.

Authors:  Elliot B Tapper; Sophia Korovaichuk; Jad Baki; Sydni Williams; Samantha Nikirk; Akbar K Waljee; Neehar D Parikh
Journal:  Clin Gastroenterol Hepatol       Date:  2019-12-27       Impact factor: 11.382

6.  Advanced liver fibrosis and the metabolic syndrome in a primary care setting.

Authors:  Andrew D Schreiner; Jingwen Zhang; Valerie Durkalski-Mauldin; Sherry Livingston; Justin Marsden; John Bian; Patrick D Mauldin; William P Moran; Don C Rockey
Journal:  Diabetes Metab Res Rev       Date:  2021-04-09       Impact factor: 4.876

7.  Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID-19.

Authors:  Terry Cheuk-Fung Yip; Vincent Wai-Sun Wong; Grace Chung-Yan Lui; Viola Chi-Ying Chow; Yee-Kit Tse; Vicki Wing-Ki Hui; Lilian Yan Liang; Henry Lik-Yuen Chan; David Shu-Cheong Hui; Grace Lai-Hung Wong
Journal:  Hepatology       Date:  2021-06-21       Impact factor: 17.298

8.  The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care.

Authors:  Andrew D Schreiner; William P Moran; Jingwen Zhang; Sherry Livingston; Justin Marsden; Patrick D Mauldin; David Koch; Mulugeta Gebregziabher
Journal:  J Gen Intern Med       Date:  2022-01-19       Impact factor: 6.473

9.  Complications Associated With Anesthesia Services in Endoscopic Procedures Among Patients With Cirrhosis.

Authors:  Sarah R Lieber; Benjamin J Heller; Christopher W Howard; Robert S Sandler; Seth Crockett; Alfred Sidney Barritt
Journal:  Hepatology       Date:  2020-12       Impact factor: 17.425

10.  Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes.

Authors:  Tracey G Simon; Elisabetta Patorno; Sebastian Schneeweiss
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-10       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.